Qiuyang Xu

1PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Aug 10, 2026
PARP Inhibitors plus Anlotinib as Bridging Therapy for Armored CAR-T Cells in Ovarian Cancer Enhances Infiltration and Antitumor Efficacy.

Pageof 1

Frequent Collaborators

1 joint publications

Huayi Li

1 joint publications

Minghua Xiang

1 joint publications

Yixin Hu

1 joint publications

Jundong Li